Corante

About this Author
Gwen Smith Ishmael, Sr. Vice President of Insights and Innovation at Decision Analyst in Arlington, TX, has led marketing and new product development activities in the CPG and technology industries since 1986. She also conceived and developed ground-breaking Web-based promotional vehicles, two of which are patent pending. Gwen holds an MBA in Marketing and is a featured speaker on insights and innovation around the world. Her writings have been featured in international text books, most recently in Managing 4 Ps of Marketing FMCG Sector, and Product Innovation: A Strategic Tool for Growth, by ICFAI Publications, 2006 and 2007, respectively.

Founding Author

Renee Hopkins Callahan Renee Hopkins Callahan started IdeaFlow and serves as chief blog-wrangler. She is Director of Innovation Services at Decision Analyst in Arlington, Texas, is a former journalist who worked as an editor and reporter for The Dallas Morning News and the Nashville Tennessean, and was managing editor of D, the Dallas city magazine. She has a master's degree in rhetoric and has also taught college-level English and informal logic.
Just Released the 2008 Tribalization of Business study - an in-depth look at how 140+ organizations are managing and measuring online communities

IdeaFlow

« Link Found Between Creativity and Madness | Main | Guide To Innovation Convergence Notes »

October 9, 2003

Better Innovation Through Neuroceuticals

Email This Entry

Posted by Renee Hopkins Callahan

After finding out about this newly discovered link between madness and creativity, I was ready to go have a drink and ponder how close to psychosis I personally might be….maybe just a few IQ points or notches of ability to multi-task and remember! Meanwhile, our ever-steady Corante blog-neighbor Zack Lynch, who’s writing a book on neurotechnology and society, had this to say:

As different aspects of mental health are better understood, more parts of the innovative process will be impacted such as accelerating learning via cogniceuticals to enhancing interpersonal communication with emoticeuticals. As neuroceutical usage spreads across industries it will create a new economic “playing field” wherein individuals who use neuroceuticals will achieve a higher level of productivity than those who don’t.

The resulting competitive gap will be substantial. To put this in historical perspective, imagine the competitive advantage that a team living in the year 2003 with the Internet as their information source has over a group living in 1953 that must rely on the local library.

Disruptive innovation, anyone?! Definitely read the whole thing.

Comments (0) | Category: Brain Chemistry & Creativity | Creativity | Disruptive Innovation



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Innovation Of A Tradition
We Hear Them, But Do We Know What They're Saying?
Farewell from Renee -- but check out the new IdeaFlow blogroll!
Supernova 2007 blog conversation: It's all about innovation and value
Innovation Bloggers Virtual Forum cancelled!!!
Join us at the first-ever Innovation Bloggers Virtual Forum, Thursday, April 26
Jack’s Notebook: A Business Novel of ‘Deliberate Creativity’
Models for crowdsourcing -- now, FLIRT